Anti-coagulation factor XI antibodies
US11512142B2 · kind B2 · utility
0Cited by
36References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 1, 2020 |
| Grant date | Nov 29, 2022 |
| Priority date | — |
| Expiry date | Jan 18, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that bind the apple 3 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa as well as activation of FIX by FXIa are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.